The cardiovascular discussion is especially important after the FDA approval of Wegovy for reducing major cardiovascular events in certain adults with established cardiovascular disease and overweight or obesity
References Sies, H
It can be produced by the body itself, but is also influenced by nutrition, stress levels, sleep quality and exposure to environmental stressors
99.15% purity independently blind-tested by Janoshik #165920 Verify CAS Number 2381089-83-2 Molecular Formula Synthetic peptide (MW 4731.3 Da) HPLC Purity 99% (batch-verified) Form Lyophilised powder Storage 28C, desiccated, protected from light Classification Research reagent - in vitro use only Retatrutide research overview Retatrutide is a synthetic peptide engineered to act as a triple agonist at three distinct G protein-coupled receptors: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
This Gq/11-coupled receptor is expressed primarily in somatotropic cells of the anterior pituitary and in certain hypothalamic areas (arcuate nucleus, paraventricular nucleus)
For those using oral contraceptives , precautions depend on which weight loss medication you're taking: With semaglutide (Wegovy) or liraglutide (Saxenda): No routine additional contraception is required based on product information With tirzepatide: Use a non-oral contraceptive method or add barrier methods (condoms) for 4 weeks after starting treatment and for 4 weeks after each dose increase If you experience vomiting or diarrhoea while taking oral contraceptives: If you vomit within 3 hours of taking your pill, follow the missed pill guidance for your specific pill type If you have severe diarrhoea lasting more than 24 hours, follow missed pill guidance Consider emergency contraception if you've had unprotected intercourse during this time Barrier methods alone (condoms, diaphragms) remain unaffected by weight loss medications but have higher typical-use failure rates (1318%) and require consistent, correct use
